Hayfin Capital Management logo

Hayfin Capital Management

Europe, England, United Kingdom, London

Description

Hayfin Capital Management is an independent investment firm that offers lending solutions to European middle-market companies.

Investor Profile

Hayfin Capital Management has made 13 investments, with 3 in the past 12 months and 69% as lead.

Stage Focus

  • Debt Financing (31%)
  • Post Ipo Debt (31%)
  • Series Unknown (23%)
  • Series F (8%)
  • Convertible Note (8%)

Country Focus

  • United States (77%)
  • Ireland (8%)
  • Germany (8%)
  • Canada (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Financial Services
  • Fintech
  • Lending
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hayfin Capital Management frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
HealthCor Partners
North America, South Carolina, United States, Charleston
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 2
OC
Europe, Dublin, Ireland, Blackrock
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 2
Capricorn Investment Group
North America, California, United States, Palo Alto
Co-Investments: 2
Martis Capital
North America, California, United States, Palo Alto
Co-Investments: 2

What are some of recent deals done by Hayfin Capital Management?

Heartflow

Mountain View, California, United States

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Convertible NoteMar 26, 2025
Amount Raised: $98,000,000
MolecuLight

Toronto, Ontario, Canada

MolecuLight develops portable handheld optical imaging devices for point-of-care wound analysis.

Health CareMedicalMedical Device
Series UnknownJan 6, 2025
Amount Raised: $27,500,000
Cosette Pharmaceuticals

Bridgewater, New Jersey, United States

Cosette Pharmaceuticals is a generic pharmaceutical company that specializes in the areas of dermatology and allergy.

BiotechnologyHealth CareMedicalPharmaceutical
Debt FinancingJul 17, 2024
Xeris Biopharma

Chicago, Illinois, United States

Xeris Biopharma is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.

BiotechnologyDiabetesHealth CarePharmaceuticalTherapeutics
Post Ipo DebtMar 6, 2024
Amount Raised: $200,000,000
HeartFlow

Mountain View, California, United States

HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Series FApr 6, 2023
Amount Raised: $215,000,000
KEO World

Miami, Florida, United States

KEO World provides digital inventory financing and B2B payment solutions that streamline the financial process between buyers and suppliers.

Financial ServicesFinTechLendingSmall and Medium Businesses
Series UnknownJun 14, 2022
Amount Raised: $20,000,000
ADMA Biologics

Ramsey, New Jersey, United States

ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.

BiotechnologyHealth CareManufacturingMedical
Post Ipo DebtMar 24, 2022
Amount Raised: $150,000,000
KEO World

Miami, Florida, United States

KEO World provides digital inventory financing and B2B payment solutions that streamline the financial process between buyers and suppliers.

Financial ServicesFinTechLendingSmall and Medium Businesses
Debt FinancingFeb 1, 2022
Amount Raised: $500,000,000
Amicus Therapeutics

Cranbury, New Jersey, United States

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo DebtJul 17, 2020
Amount Raised: $400,000,000
MiMedx Group

Marietta, Georgia, United States

MiMedx Group is a wound care and a therapeutic biologics company.

BiotechnologyHealth CareMarketingMedicalMedical DeviceWellness
Post Ipo DebtJul 2, 2020
Amount Raised: $50,000,000